252 related articles for article (PubMed ID: 8751855)
1. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
[TBL] [Abstract][Full Text] [Related]
2. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT
Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 in breast cancer.
Yang X; Lippman ME
Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
8. The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
Peelen T; Cornelis RS; van Vliet M; Petrij-Bosch A; Cleton-Jansen AM; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; Devilee P
Eur J Hum Genet; 1996; 4(4):225-30. PubMed ID: 8875189
[TBL] [Abstract][Full Text] [Related]
9. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
[TBL] [Abstract][Full Text] [Related]
12. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
Serova OM; Mazoyer S; Puget N; Dubois V; Tonin P; Shugart YY; Goldgar D; Narod SA; Lynch HT; Lenoir GM
Am J Hum Genet; 1997 Mar; 60(3):486-95. PubMed ID: 9042907
[TBL] [Abstract][Full Text] [Related]
13. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
Ford D; Easton DF; Stratton M; Narod S; Goldgar D; Devilee P; Bishop DT; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare MD; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck TR; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder BA; Gayther SA; Zelada-Hedman M
Am J Hum Genet; 1998 Mar; 62(3):676-89. PubMed ID: 9497246
[TBL] [Abstract][Full Text] [Related]
15. Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
Tonin P; Moslehi R; Green R; Rosen B; Cole D; Boyd N; Cutler C; Margolese R; Carter R; McGillivray B
Hum Genet; 1995 May; 95(5):545-50. PubMed ID: 7759076
[TBL] [Abstract][Full Text] [Related]
16. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
[TBL] [Abstract][Full Text] [Related]
17. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
[TBL] [Abstract][Full Text] [Related]
18. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
Kainu T; Juo SH; Desper R; Schaffer AA; Gillanders E; Rozenblum E; Freas-Lutz D; Weaver D; Stephan D; Bailey-Wilson J; Kallioniemi OP; Tirkkonen M; Syrjäkoski K; Kuukasjärvi T; Koivisto P; Karhu R; Holli K; Arason A; Johannesdottir G; Bergthorsson JT; Johannsdottir H; Egilsson V; Barkardottir RB; Johannsson O; Haraldsson K; Sandberg T; Holmberg E; Grönberg H; Olsson H; Borg A; Vehmanen P; Eerola H; Heikkila P; Pyrhönen S; Nevanlinna H
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9603-8. PubMed ID: 10944226
[TBL] [Abstract][Full Text] [Related]
19. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
Tonin PN; Mes-Masson AM; Futreal PA; Morgan K; Mahon M; Foulkes WD; Cole DE; Provencher D; Ghadirian P; Narod SA
Am J Hum Genet; 1998 Nov; 63(5):1341-51. PubMed ID: 9792861
[TBL] [Abstract][Full Text] [Related]
20. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
